Genmab — September 2020
-
Tillykke med det, Monforte
-
EL sorry I wasn’t precise. The procedure for my visits at Vejle is every second time with a nurse and a dr and every second time with a nurse. Today it was first meeting with the dr. He ask if I have heard about the new sc which I confirmed. He told me about the difference between ivy and sc. then I asked for sc. the nurse, who gave me the sc said that they had been given sc for ordinary patient for about 14 days.
-
God morgen.
-
Godmorgen på denne halvgrå tirsdag
-
Bernstein hæver kursmål til 2400 fra 2275 - uden videre info om deres opdaterede vurdering https://www.euroinvestor.dk/nyheder/ge
nmab-kursmaal-haeves-til-2400-kr-fra-2275-kr -
-
Tak LLI.
-
Proinvestor har webinar med høreapparatudvikleren Audientes i aften kl. 19,30 i anledning af virksomhedens kommende børsnotering. Tilmelding på linkhttps://nyemission.dk/audientes/
-
Novartis data at ACTRIMS-ECTRIMS highlight the strength of leading multiple sclerosis (MS) portfolio - Novartis will present 48 abstracts from its leading MS portfolio, including new data on recently FDA-approved Kesimpta
(ofatumumab) - https://www.novartis.com/news/media-releases/novartis-data-actrims-ectrims-highlight-strength-leading-multiple-sclerosis-ms-portfolio-life-changing-therapies-people-across-ms-spectrum
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind